Zhejiang CONBA PharmaceuticalLtd Balance Sheet Health
Financial Health criteria checks 6/6
Zhejiang CONBA PharmaceuticalLtd has a total shareholder equity of CN¥7.5B and total debt of CN¥1.1B, which brings its debt-to-equity ratio to 14.2%. Its total assets and total liabilities are CN¥11.3B and CN¥3.8B respectively. Zhejiang CONBA PharmaceuticalLtd's EBIT is CN¥533.4M making its interest coverage ratio -4.9. It has cash and short-term investments of CN¥2.4B.
Key information
14.2%
Debt to equity ratio
CN¥1.06b
Debt
Interest coverage ratio | -4.9x |
Cash | CN¥2.37b |
Equity | CN¥7.47b |
Total liabilities | CN¥3.84b |
Total assets | CN¥11.31b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 600572's short term assets (CN¥5.9B) exceed its short term liabilities (CN¥3.0B).
Long Term Liabilities: 600572's short term assets (CN¥5.9B) exceed its long term liabilities (CN¥813.1M).
Debt to Equity History and Analysis
Debt Level: 600572 has more cash than its total debt.
Reducing Debt: 600572's debt to equity ratio has reduced from 56.4% to 14.2% over the past 5 years.
Debt Coverage: 600572's debt is well covered by operating cash flow (92.2%).
Interest Coverage: 600572 earns more interest than it pays, so coverage of interest payments is not a concern.